Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.
The prevalence of carbapenemase-producing Enterobacteriaceae (CPE) has been increasing worldwide. blaIMP has been reported to be the predominant carbapenemase-encoding gene within Enterobacteriaceae in Australia. However, there are limited data currently available on CPE from Queensland, Australia. A total of 58 CPE isolates were isolated between July 2009 and March 2014 from Queensland hospitals. The clonality of isolates was determined by Diversilab repetitive sequence-based PCR. The isolates were investigated for the resistance mechanisms carbapenemase, extended-spectrum β-lactamase, and AmpC β-lactamase and for aminoglycoside resistance and plasmid-mediated quinolone resistance genes by PCR. The plasmid types associated with carbapenemase-encoding genes were characterized. The majority of the CPE were Enterobacter cloacae (n = 29). The majority of Queensland CPE isolates were IMP producers and comprised 11 species (n = 48). Nine NDM-producing Enterobacteriaceae were identified. One NDM-producing Klebsiella pneumoniae isolate coproduced OXA-48. One K. pneumoniae isolate was an OXA-181 producer. The incidence of IMP producers increased significantly in 2013. blaIMP-4 was found in all IMP-producing isolates. blaTEM, qnrB, and aacA4 were common among IMP-4 producers. The HI2 (67%) and L/M (21%) replicons were associated with blaIMP-4. All HI2 plasmids were of sequence type 1 (ST1). All but one of the NDM producers possessed blaCTX-M-15. The 16S rRNA methylase genes found among NDM producers were armA, rmtB, rmtC, and rmtF. The substantial increase in the prevalence of CPE in Queensland has been associated mainly with the emergence E. cloacae strains possessing HI2 plasmids carrying blaIMP-4 over the past 2 years. The importation of NDM producers and/or OXA-48-like producers in patients also contributed to the increased emergence of CPE.
University of Queensland, UQ Centre for Clinical Research, Brisbane, Queensland, Australia h.sidjabat@uq.edu.au.
Hanna E
HE
Sidjabat
Pathology Queensland, Brisbane, Queensland, Australia.
Nicola
N
Townell
Pathology Queensland, Brisbane, Queensland, Australia.
Graeme R
GR
Nimmo
Pathology Queensland, Brisbane, Queensland, Australia.
Narelle M
NM
George
Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia.
Jennifer
J
Robson
QML Pathology, Brisbane, Queensland, Australia.
Renu
R
Vohra
Communicable Diseases Unit, Department of Health, Brisbane, Queensland, Australia.
Louise
L
Davis
Pathology Queensland, Brisbane, Queensland, Australia.
Claire
C
Heney
University of Queensland, UQ Centre for Clinical Research, Brisbane, Queensland, Australia Pathology Queensland, Brisbane, Queensland, Australia.
David L
DL
Paterson
D001315:Australia / Q000453:epidemiology; D001426:Bacterial Proteins / Q000096:biosynthesis* / Q000235:genetics; D024881:Drug Resistance, Bacterial / Q000235:genetics; D016972:Enterobacter cloacae / Q000187:drug effects / Q000235:genetics*; D004755:Enterobacteriaceae / Q000187:drug effects / Q000235:genetics*; D004756:Enterobacteriaceae Infections / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000235:genetics; D010957:Plasmids; D015995:Prevalence; D011793:Queensland / Q000453:epidemiology; D012329:RNA, Bacterial / Q000235:genetics; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D001618:beta-Lactamases / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism*
D001426:Bacterial Proteins; D012329:RNA, Bacterial; D012336:RNA, Ribosomal, 16S; C425142:beta-lactamase IMP-4; D001618:beta-Lactamases; C063912:carbapenemase